Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mouton

Showing results (71-80 of 392) with videos related to

Pageof 40
Sort By:
Helvetica Chirurgica Acta|July 1, 1991
[Myocutaneous latissimus dorsi sliding flap in reconstruction of the lower thoracic wall in chronic fistula caused by cystic echinococcosis of the liver]W Mouton, W Schweizer, J C Zuber, et al.
Current Opinion in Pharmacology|September 6, 2011
Assessment of efficacy of antifungals in experimental models of invasive aspergillosis in an era of emerging resistance: the value of real-time quantitative PCRSeyedmojtaba Seyedmousavi, Willem J G Melchers, Paul E Verweij, et al.
Clinical Pharmacokinetics|October 6, 2000
Comparative pharmacokinetics of the carbapenems: clinical implicationsJ W Mouton, D J Touzw, A M Horrevorts, et al.
Pediatric Pulmonology|November 7, 2000
Aerosol therapy in cystic fibrosis: a survey of 54 CF centersP Borsje, J C de Jongste, J W Mouton, et al.
Antimicrobial Agents and Chemotherapy|February 14, 2013
Monte Carlo simulations based on phase 1 studies predict target attainment of ceftobiprole in nosocomial pneumonia patients: a validation studyAnouk E Muller, Anne H Schmitt-Hoffmann, Nieko Punt, et al.
Expert Review of Anti-Infective Therapy|September 24, 2013
Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosisSeyedmojtaba Seyedmousavi, Johan W Mouton, Paul E Verweij, et al.
Antimicrobial Agents and Chemotherapy|February 12, 2014
Susceptibility breakpoints for amphotericin B and Aspergillus species in an in vitro pharmacokinetic-pharmacodynamic model simulating free-drug concentrations in human serumA Elefanti, J W Mouton, P E Verweij, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1999
Use of pharmacodynamic indices to predict efficacy of combination therapy in vivoJ W Mouton, M L van Ogtrop, D Andes, et al.
Clinical Pharmacokinetics|January 13, 1999
Pharmacokinetic optimisation of antibacterial treatment in patients with cystic fibrosis. Current practice and suggestions for future directionsD J Touw, A A Vinks, J W Mouton, et al.
Allergy|April 1, 1985
Non-steroid anti-inflammatory drugs in asthma: dangerous or useful therapy?J R Joubert, E Shephard, W Mouton, et al.
Pageof 40

Showing results (71-80 of 392) with videos related to

Sort By:
Pageof 40
Helvetica Chirurgica Acta|July 1, 1991
[Myocutaneous latissimus dorsi sliding flap in reconstruction of the lower thoracic wall in chronic fistula caused by cystic echinococcosis of the liver]W Mouton, W Schweizer, J C Zuber, et al.
Current Opinion in Pharmacology|September 6, 2011
Assessment of efficacy of antifungals in experimental models of invasive aspergillosis in an era of emerging resistance: the value of real-time quantitative PCRSeyedmojtaba Seyedmousavi, Willem J G Melchers, Paul E Verweij, et al.
Clinical Pharmacokinetics|October 6, 2000
Comparative pharmacokinetics of the carbapenems: clinical implicationsJ W Mouton, D J Touzw, A M Horrevorts, et al.
Pediatric Pulmonology|November 7, 2000
Aerosol therapy in cystic fibrosis: a survey of 54 CF centersP Borsje, J C de Jongste, J W Mouton, et al.
Antimicrobial Agents and Chemotherapy|February 14, 2013
Monte Carlo simulations based on phase 1 studies predict target attainment of ceftobiprole in nosocomial pneumonia patients: a validation studyAnouk E Muller, Anne H Schmitt-Hoffmann, Nieko Punt, et al.
Expert Review of Anti-Infective Therapy|September 24, 2013
Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosisSeyedmojtaba Seyedmousavi, Johan W Mouton, Paul E Verweij, et al.
Antimicrobial Agents and Chemotherapy|February 12, 2014
Susceptibility breakpoints for amphotericin B and Aspergillus species in an in vitro pharmacokinetic-pharmacodynamic model simulating free-drug concentrations in human serumA Elefanti, J W Mouton, P E Verweij, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1999
Use of pharmacodynamic indices to predict efficacy of combination therapy in vivoJ W Mouton, M L van Ogtrop, D Andes, et al.
Clinical Pharmacokinetics|January 13, 1999
Pharmacokinetic optimisation of antibacterial treatment in patients with cystic fibrosis. Current practice and suggestions for future directionsD J Touw, A A Vinks, J W Mouton, et al.
Allergy|April 1, 1985
Non-steroid anti-inflammatory drugs in asthma: dangerous or useful therapy?J R Joubert, E Shephard, W Mouton, et al.
Pageof 40